| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 05/30/2002 | US20020065393 Human hypoxanthine- (guanine) phosphoribosy1 transferase-2 |
| 05/30/2002 | US20020065391 Compound for use in the treatment of arthritis, inflammatory bowel disease, nervous system and cardiovascular disorders, arteriosclerosis, restenoses, diabetes, grafted organ damage, asthma, allergies, tumor metastasis and malaria |
| 05/30/2002 | US20020065308 EP4 receptor selective agonists in the treatment of osteoporosis |
| 05/30/2002 | US20020065302 Cyclic AMP-specific phosphodiesterase inhibitors |
| 05/30/2002 | US20020065296 Administering heteroarylurea compound for therapy of cytokine mediated diseases and proteolytic enzyme mediated diseases |
| 05/30/2002 | US20020065285 Aromatic heterocyclic compounds as antiinflammatory agents |
| 05/30/2002 | US20020065284 Dipeptide derivatives |
| 05/30/2002 | US20020065269 3-Sulfonylamino-c5 to c8-methyleneimino-2-carboxylic acid compound is effective for prophylaxis and treatment of inflammation, tissue degradation, cancer, fibrosis and related diseases |
| 05/30/2002 | US20020065231 Method for producing biologically active products |
| 05/30/2002 | US20020065230 Bis(aminomethyl)carbonyl compounds as inhibitors of cysteine protease (cathepsin K) and serine proteases; bone or cartilage loss, e.g., osteoporosis, periodontitis; antiarthritic agents; rheumatic diseases; gingivitis |
| 05/30/2002 | US20020064856 Novel proteases |
| 05/30/2002 | US20020064843 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 05/30/2002 | US20020064823 Nucleotide sequences which code binding protein for use in human therapeutics and gene therapy |
| 05/30/2002 | US20020064566 Neutral to mildly alkaline; preventing and/or treating certain inflammatory diseases and/or degenerative diseases and/or certain viral diseases in a mammal |
| 05/30/2002 | US20020064527 Administering agents that hinder CD30/CD30L (CD30L=ligand of CD30) binding; animal model of arthritis for drug screening |
| 05/30/2002 | US20020064524 Formulation for topical non-invasive application in vivo |
| 05/30/2002 | US20020064519 Administering non-autologous (allogeneic) mesenchymal stem cells (they are "invisible" to the immune system) to promote hematopoietic or progenitor cell engraftment; use as host cells in gene therapy or in tissue repair |
| 05/30/2002 | US20020064516 Pharmaceutical compositions comprising TGF-beta |
| 05/30/2002 | CA2429630A1 Imidazole and benzimidazole caspase inhibitors and uses thereof |
| 05/30/2002 | CA2429605A1 Indol derivative and their use as inhibitors of p38 kinase |
| 05/30/2002 | CA2429579A1 Truncated cd200 |
| 05/30/2002 | CA2429570A1 Pyrimidine derivatives |
| 05/30/2002 | CA2429442A1 Aminothiazoles and their use as adenosine receptor antagonists |
| 05/30/2002 | CA2428191A1 Acid derivatives useful as serine protease inhibitors |
| 05/30/2002 | CA2427444A1 3-arylindole derivatives and their use as cb2 receptor agonists |
| 05/30/2002 | CA2427284A1 Antiinflammation agents |
| 05/30/2002 | CA2426929A1 Treatment of osteoporosis |
| 05/30/2002 | CA2363935A1 Therapy for andropause using estrogen agonists/antagonists and testosterone |
| 05/29/2002 | EP1208850A1 Pastes with the sustained release of osteogenesis promoter |
| 05/29/2002 | EP1208849A1 Use of bromelain for the treatment of inflammatory diseases and for adjuvant therapy during wound healing process |
| 05/29/2002 | EP1208202A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 05/29/2002 | EP1208201A2 Compositions and methods for the treatment of immune related diseases |
| 05/29/2002 | EP1208198A2 Egfh2 genes and gene products |
| 05/29/2002 | EP1208196A1 15571, a novel gpcr-like molecule of the secretin-like family and uses thereof |
| 05/29/2002 | EP1208103A2 Reverse-turn mimetics and methods relating thereto |
| 05/29/2002 | EP1208100A1 Selective antagonists of a2b adenosine receptors |
| 05/29/2002 | EP1208097A2 Substituted oxoazaheterocyclyl compounds |
| 05/29/2002 | EP1208096A1 Substituted pyridazines and fused pyridazines with angiogenesis inhibiting activity |
| 05/29/2002 | EP1208092A1 Sulfonamide derivative as a matrix metalloproteinase inhibitor |
| 05/29/2002 | EP1208088A2 Fluorene derivatives as integrin inhibitors |
| 05/29/2002 | EP1207905A1 Methods and compositions for treatment of inflammatory disease using cadherin-11 modulating agents |
| 05/29/2002 | EP1207896A1 Methods and compositions for reducing serum phosphate levels |
| 05/29/2002 | EP1207882A1 Acyclic and cyclic amine derivatives |
| 05/29/2002 | EP1207873A1 Methods of inhibiting osteoclast activity |
| 05/29/2002 | EP1207863A2 New uses for potassium channel openers, such as the treatment of epilepsy |
| 05/29/2002 | EP1207862A2 Arthritis treatment |
| 05/29/2002 | EP1207856A2 Coformulation methods and their products |
| 05/29/2002 | EP1207855A1 Pharmaceutical composition comprising nabumetone |
| 05/29/2002 | EP1207755A1 Methods of and compositions for inhibiting the proliferation of mammalian cells |
| 05/29/2002 | CN1351614A Human antibodies that bind human IL-12 and methods for producing |
| 05/29/2002 | CN1351609A Low-molecular inhibitors of complement proteases |
| 05/29/2002 | CN1351604A Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease |
| 05/29/2002 | CN1351602A New pharmaceutically active compounds |
| 05/29/2002 | CN1351601A Heterocyclic compounds binding chemotactic factor receptor |
| 05/29/2002 | CN1351599A Indole-type derivatives as inhibitors of P38 kinase |
| 05/29/2002 | CN1351598A Substituted phenyl compounds with immunosuppressing activity and pharmaceutical compositions |
| 05/29/2002 | CN1351589A Vitamin D analogues and their pharmaceutical use |
| 05/29/2002 | CN1351490A Use of 15-deoxyspergualin for the treatment of hyperreactive inflammatory diseases and autoimmune diseases |
| 05/29/2002 | CN1351471A Heath-care food for joints of pet |
| 05/29/2002 | CN1085687C Polymeric matrices and their uses in pharmaceutial compositions |
| 05/28/2002 | US6395919 Calcilytic compounds |
| 05/28/2002 | US6395911 Process for cis-1{2-[4-(6-methoxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenoxy] ethyl}pyrrolidine |
| 05/28/2002 | US6395784 Obesity, hypercholesterolemia, atherosclerosis, thyroid cancer, hypothyroidism, osteoporosis, depression, arrhythmia, and congestive heart failure treatment |
| 05/28/2002 | US6395769 2-arylbenzo[b]thiophenes useful for the treatment of estrogen deprivation syndrome |
| 05/28/2002 | US6395767 Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method |
| 05/28/2002 | US6395763 Antitumor, anticancer agents; immunosuppressant |
| 05/28/2002 | US6395754 Antiinflammatory agents, cardiovascular disorders, antipyretics |
| 05/28/2002 | US6395740 Calcitonin mimetics |
| 05/28/2002 | US6395734 Anticancer agents |
| 05/28/2002 | US6395511 Nuclelotide sequences coding regulatory protein; for usein treatment of bone disorders |
| 05/28/2002 | US6395502 Method and means for modulating PGE synthase activity |
| 05/28/2002 | US6395313 Ngali nut oil |
| 05/28/2002 | US6395309 Use of an extract of Alchemilla vulgaris to inhibit angiogenesis |
| 05/28/2002 | US6395308 For the treatment of asthma bronchiale, colitis ulcerosa, morbus crohn, diseases of the rheumatic type, and indications in which an increase of the lipoxygenase level occurs either by medicaments, other substances or diseases. |
| 05/28/2002 | US6395291 Use for pain management |
| 05/28/2002 | US6395279 Mixture of at least two phytochemicals including isoflavones, lignins, saponins, catechins, and phenolic acids |
| 05/28/2002 | CA2083274C The pharmacological use of certain cystine derivatives |
| 05/23/2002 | WO2002040671A2 Immunoglobulin superfamily proteins |
| 05/23/2002 | WO2002040666A2 Fat regulated genes, uses thereof, and compounds for modulating same |
| 05/23/2002 | WO2002040517A2 M. tuberculosis chaperonin 60.1 and uses thereof |
| 05/23/2002 | WO2002040505A2 Dibenzoxazepine alpha v integrin receptor antagonist |
| 05/23/2002 | WO2002040498A2 Reduction of antioxidant enzyme levels in tumor cells using antisense oligonucleotides |
| 05/23/2002 | WO2002040486A2 METHODS OF TREATING p38 KINASE-ASSOCIATED CONDITIONS AND PYRROLOTRIAZINE COMPOUNDS USEFUL AS KINASE INHIBITORS |
| 05/23/2002 | WO2002040476A1 Pyridyl-substituted triazoles as tgf inhibitors |
| 05/23/2002 | WO2002040468A1 Compounds |
| 05/23/2002 | WO2002040450A1 (dihydro)isoquinoline derivatives as phosphodiesterase inhibitors |
| 05/23/2002 | WO2002040051A1 Colostrum-based composition |
| 05/23/2002 | WO2002040041A2 Orally ingestible preparation of mistletoe lectins and method |
| 05/23/2002 | WO2002040038A2 M. tuberculosis chaperonin 10 and uses thereof |
| 05/23/2002 | WO2002040037A2 M. tuberculosis chaperonin 60.1 and uses thereof |
| 05/23/2002 | WO2002040025A1 Anti-inflammatory agents |
| 05/23/2002 | WO2002040020A1 Novel use of certain insulin sensitizers or ppar-gamma agonists |
| 05/23/2002 | WO2002040016A2 Association of calpain inhibitors and reactive oxygen species trapping agents |
| 05/23/2002 | WO2002040007A1 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |
| 05/23/2002 | WO2002039988A2 Novel uses of combined selective dopamine d2 receptor antagonists and 5-ht1a receptor agonists |
| 05/23/2002 | WO2002039954A2 Novel compounds |
| 05/23/2002 | WO2002039834A1 Nutritional composition for an immune condition |
| 05/23/2002 | WO2002006213A3 Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids |
| 05/23/2002 | WO2002005823A3 USE OF 2-METHYLENE-19-NOR-20(S)-1α,25-DIHYDROXYVITAMIN D3 TO INCREASE BONE STRENGTH |
| 05/23/2002 | WO2001093701A3 Aqueous chondroprotective compositions having defined ph limitations for efficacious delivery |